Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
about
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsOutcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisNevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected PatientsEfavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsPatient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa.Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings.Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico.Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis.Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study.Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa.A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults.Association between efavirenz-based compared with nevirapine-based antiretroviral regimens and virological failure in HIV-infected children.MACH14: a multi-site collaboration on ART adherence among 14 institutionsProjecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities.Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.Literacy, education and adherence to antiretroviral therapy in The Gambia.Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.Choice of initial antiretroviral drugs and treatment outcomes among HIV-infected patients in sub-Saharan Africa: systematic review and meta-analysis of observational studies.Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients.Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity.Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine.
P2860
Q24235724-3C9995E1-99A3-4AC4-B641-D3917060F6DBQ27021762-435727FE-D6C2-4BF0-9068-6C29E2971F52Q28548003-4DE0B148-A817-4238-88E1-4C4A7B19504BQ30240127-B5AB4FDD-54C2-46E0-B692-A2D878EA0242Q33619740-A844ABB4-9277-47E3-8F49-2AB404EDD387Q33830775-BF62A62D-39B3-4C33-A411-689B540D0E07Q34252288-82BC54C9-31BA-4411-BC1A-040C366EBC02Q34433397-1A1A1FC7-D0CC-43B6-A6D3-60F700C36D02Q34571594-D9305431-F643-4F11-BAEB-AB9862CB9CF0Q34574727-877DE318-9333-4D3D-8C71-33743CA6D168Q34768650-FCF616C9-9C53-4094-BA06-02135327BDC5Q34927469-8E2DE0CA-B224-4F75-9DD2-6F5ED367D920Q35059630-3103FAD8-5450-4D07-801B-BABA9AB88261Q35576031-7D7D7848-62AB-487F-9167-DA1324A714B3Q35717749-FCC07CA3-F543-4924-89A6-5BB5684BBEC7Q35737660-1B0CA576-AA01-4FE9-A81C-90997B9AD2D1Q35771321-BCE2A710-9FF3-44A6-85E2-437DA16ADD91Q35930384-D2384545-0227-457D-9906-046178BD4638Q37002481-30746B62-D056-4DE4-8E62-FB05D286FC3AQ37108384-29D5B4C5-4CB3-4851-BE8F-C471B473570BQ37160388-DF8AF699-3A37-4FAD-A40D-EF7F78C9634CQ37326983-71B28C10-C1E7-4CFC-ACBA-AD132A498EC0Q37415603-DB76FC71-3A27-43F9-8621-124CD9681573Q37491656-8E2538B3-5FD2-4232-A07A-0CF1D5D7EDAFQ37628307-7DBF3FF1-BAF9-4FCA-B7EC-6D7FD1E0A35AQ38861593-311F1C49-C2C2-4AA9-A547-8FF42275B7F9Q39062183-87501EE9-0355-4ACD-8107-E29053E42E8DQ39557809-57E1806E-6358-4AFD-AE29-28C963BA8285Q39741284-52AC75B1-94F9-4A70-A15D-DC7BF4DB1588Q40070125-573DA2A8-91A0-4944-97BA-BB197EBE2930Q40280595-759B4481-FC68-4DFD-9367-017B1DC8101AQ40577108-7A6658DD-D9F6-4617-9940-C405987DED71Q41769995-D2CDD331-AA98-4A9C-9198-7EFDBE50F069
P2860
Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@en
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@nl
type
label
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@en
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@nl
prefLabel
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@en
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@nl
P2093
P2860
P1433
P1476
Efavirenz versus nevirapine-ba ...... es in Southern African adults.
@en
P2093
David W Dowdy
Jean B Nachega
Joel E Gallant
Leon Regensberg
Michael Hislop
P2860
P304
P356
10.1097/QAD.0B013E328310407E
P407
P577
2008-10-01T00:00:00Z